Lung Cancer Archives - Pulmonology Advisor

COVID-19 Pandemic Has Affected Lung Cancer Treatment Plans

September 25, 2020

More than half of patients have experienced changes in their lung cancer treatment plan as a result of the COVID-19 pandemic.

General Pulmonology

The Role of Artificial Intelligence in Pulmonary Imaging: Clinician Interview

By

Tori Rodriguez, MA, LPC, AHC

September 16, 2020

Artificial intelligence has the potential to ease the workload of physicians while increasing the speed and accuracy of diagnosis, particularly in pulmonology.

Lung Cancer

Is the Increase in Teen Vaping Affecting Lung Cancer Rates?

By

Steve Fiorillo

September 14, 2020

E-cigarette use among teens and young people has been a medical concern ever since the product hit the market. By 2018, the US Surgeon General had referred to vaping as an “epidemic,” and the US Food and Drug Administration has spent years working to regulate the e-cigarette industry to try and curtail use. Even still,…

Lung Cancer

How to Improve LDCT Screening Rates in Persons at High Risk for Lung Cancer

By

Susan Moench, PhD, PA-C

September 11, 2020

Nurses working in primary care settings are well-situated to identify and educate patients at high risk of lung cancer who are eligible to undergo LDCT screening.

Lung Cancer

Pralsetinib Approved for Metastatic RET Fusion-Positive NSCLC

By

Brian Park, PharmD

September 10, 2020

The FDA has approved Gavreto™ (pralsetinib; Blueprint Medicines and Genentech) for the treatment of adults with metastatic RET fusion-positive NSCLC.

Lung Cancer

Tepotinib Gets Priority Review for Metastatic NSCLC With METex14 Skipping Mutation

By

Brian Park, PharmD

August 28, 2020

The FDA has granted Priority Review to tepotinib for metastatic NSCLC whose tumors have a mutation that leads to METex14 skipping.

Lung Cancer

Changes in Lung Cancer Incidence Between Black and White Young Adults

August 28, 2020

The historically higher lung cancer incidence in young Black people compared with White people has disappeared and reversed in men and women, respectively, in the United States.

Lung Cancer

Lung Cancer in the Time of COVID-19: Challenges and Solutions

By

Tori Rodriguez, MA, LPC, AHC

August 25, 2020

In the midst of the COVID-19 pandemic, patients with lung cancer face an increased risk of disease progression, reduced survival, and worse quality of life associated with delayed treatment.

Lung Infection

Cancer-Related Encounters Have Decreased Since Start of COVID-19

August 3, 2020

Researchers identified clear trends suggesting a significant decrease in all current cohorts explored, with the largest decrease in the number of patients with cancer having encounters for April 2020.

Smoking

Survivors of Smoking-Related Cancers Likely to Continue Smoking

By

Bryant Moeller

July 24, 2020

Patients with smoking-related cancers were more likely to be current smokers both before and after diagnosis compared with patients who had nonsmoking-related cancers.